BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38265254)

  • 21. Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology.
    Privé BM; Israël B; Schilham MGM; Muselaers CHJ; Zámecnik P; Mulders PFA; Witjes JA; Sedelaar M; Mehra N; Verzijlbergen F; Janssen MJR; Gotthardt M; Barentsz JO; van Oort IM; Nagarajah J
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):423-430. PubMed ID: 32999466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer.
    Tulsyan S; Das CJ; Tripathi M; Seth A; Kumar R; Bal C
    Nucl Med Commun; 2017 Dec; 38(12):1094-1102. PubMed ID: 28957842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer.
    Doan P; Counter W; Papa N; Sheehan-Dare G; Ho B; Lee J; Liu V; Thompson JE; Agrawal S; Roberts MJ; Buteau J; Hofman MS; Moon D; Lawrentschuk N; Murphy D; Stricker PD; Emmett L
    BJU Int; 2023 May; 131(5):588-595. PubMed ID: 36371669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer.
    Tran V; Hong A; Sutherland T; Taubman K; Lee SF; Lenaghan D; Sethi K; Corcoran NM; Lawrentschuk N; Woo H; Tarlinton L; Bolton D; Spelman T; Thomas L; Booth R; Hegarty J; Perry E; Wong LM
    BMJ Open; 2022 Sep; 12(9):e061815. PubMed ID: 36123093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.
    Yilmaz B; Turkay R; Colakoglu Y; Baytekin HF; Ergul N; Sahin S; Tugcu V; Inci E; Tasci AI; Cermik TF
    Prostate; 2019 Jun; 79(9):1007-1017. PubMed ID: 31012125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of [
    Mingels C; Bohn KP; Rominger A; Afshar-Oromieh A; Alberts I
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2436-2444. PubMed ID: 35067735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Ga-PSMA PET MRI with mpMRI in localization and regional staging of prostate cancer.
    Deka H; Pooleri GK; Suguna B; Rajeshkannan R; Sekhar R; Bindhu MR; Prasad V
    World J Urol; 2024 Mar; 42(1):153. PubMed ID: 38483621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the Detection Performance Between Multiparametric Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen PET/CT in Patients With Localized Prostate Cancer: A Systematic Review and Meta-analysis.
    Wang YF; Lo CY; Chen LY; Chang CW; Huang YT; Huang YY; Huang YH
    Clin Nucl Med; 2023 Jul; 48(7):e321-e331. PubMed ID: 37145456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Performance of
    Light A; Lazic S; Houghton K; Bayne M; Connor MJ; Tam H; Ahmed HU; Shah TT; Barwick TD
    J Nucl Med; 2024 Mar; 65(3):379-385. PubMed ID: 38212074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of
    Coşar U; Şen İ; Aydos U; Koparal MY; Uçar M; Tokgöz N; Gönül İI; Akdemir ÜÖ; Atay LÖ; Sözen TS
    Int J Clin Pract; 2021 Aug; 75(8):e14287. PubMed ID: 33931929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head-to-Head Comparison of
    Kuten J; Fahoum I; Savin Z; Shamni O; Gitstein G; Hershkovitz D; Mabjeesh NJ; Yossepowitch O; Mishani E; Even-Sapir E
    J Nucl Med; 2020 Apr; 61(4):527-532. PubMed ID: 31562225
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined Utility of
    Kalapara AA; Ballok ZE; Ramdave S; O'Sullivan R; Ryan A; Konety B; Grummet JP; Frydenberg M
    Eur Urol Oncol; 2022 Jun; 5(3):314-320. PubMed ID: 33741337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Status of
    Tang Y; Ji X; Lin Q; Huang H; Zhu H; Huang X; Xie H; Chen W; Zhuang Y
    World J Urol; 2023 Apr; 41(4):1017-1024. PubMed ID: 36932282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous
    Eiber M; Weirich G; Holzapfel K; Souvatzoglou M; Haller B; Rauscher I; Beer AJ; Wester HJ; Gschwend J; Schwaiger M; Maurer T
    Eur Urol; 2016 Nov; 70(5):829-836. PubMed ID: 26795686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraindividual comparison between
    Spohn S; Jaegle C; Fassbender TF; Sprave T; Gkika E; Nicolay NH; Bock M; Ruf J; Benndorf M; Gratzke C; Grosu AL; Zamboglou C
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2796-2803. PubMed ID: 32342192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison study of 68gallium-prostate-specific membrane antigen positron emission tomography-computed tomography and multiparametric magnetic resonance imaging for locoregional staging of prostate cancer.
    Patel KS; Singh T; Raghuvanshi K; Sonar S; Chaudhari R
    Urol Sci; 2024 Mar; 35(1):36-41. PubMed ID: 38566885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 68Ga-PSMA-I/T PET-CT and Multiparametric MRI for Locoregional Staging of Prostate Cancer Patients: A Pilot Study.
    Çelen S; Gültekin A; Özlülerden Y; Mete A; Sağtaş E; Ufuk F; Yüksel D; Yağcı B; Zümrütbaş AE
    Urol Int; 2020; 104(9-10):684-691. PubMed ID: 32750695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.
    Stabile A; Pellegrino A; Mazzone E; Cannoletta D; de Angelis M; Barletta F; Scuderi S; Cucchiara V; Gandaglia G; Raggi D; Necchi A; Karakiewicz P; Montorsi F; Briganti A
    Eur Urol Oncol; 2022 Feb; 5(1):1-17. PubMed ID: 34538770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancer.
    Kaufmann S; Kruck S; Gatidis S; Hepp T; Thaiss WM; Hennenlotter J; Schwenck J; Scharpf M; Nikolaou K; Stenzl A; Reischl G; la Fougère C; Bedke J
    World J Urol; 2020 Oct; 38(10):2513-2521. PubMed ID: 31907632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison between
    Frumer M; Milk N; Rinott Mizrahi G; Bistritzky S; Sternberg I; Leibovitch I; Dekel Y; Amiel GE; Zisman A; Baniel J; Haifler M; Gal J; Hoffman A; Sagy I; Rosenzweig B; Haramaty R; Golan S
    Abdom Radiol (NY); 2020 Dec; 45(12):4194-4201. PubMed ID: 32671440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.